Aquaporin 11 Variant Associates with Kidney Disease in Type 2 Diabetic Patients

Overview

Journal Am J Physiol Renal Physiol

Publisher American Physiological Society

Specialties Nephrology
Physiology

Date 2016 Jan 1

PMID 26719361

Citations 10

Authors

David P Choma

Roberto Vanacore

Helen Naylor

Ian A Zimmerman

Andrei Pavlichenko

Artyom Pavlichenko

Liberty Foye

David P Carbone

Raymond C Harris

Mikhail M Dikov

Elena E Tchekneva

Affiliations

Soon will be listed here.

Abstract

Kidney disease, a common complication of diabetes, associates with poor prognosis. Our previous animal model studies linked aquaporin (AQP)11 to acute kidney injury, hyperglycemia-induced renal impairment, and kidney disease in diabetes. Here, we report the AQP11 rs2276415 variant as a genetic factor placing type 2 diabetic patients at greater risk for the development of kidney disease. We performed two independent retrospective case-control studies in 1,075 diabetic and 1,619 nondiabetic individuals who were identified in the Synthetic Derivative Database with DNA samples in the BioVU DNA repository at Vanderbilt University (Nashville, TN). A χ(2)-test and multivariable logistic regression analysis with adjustments for age, sex, baseline serum creatinine, and underlying comorbid disease covariates showed a significant association between rs2276415 and the prevalence of any event of acute kidney injury and chronic kidney disease (CKD) in diabetic patients but not in patients without diabetes. This result was replicated in the second independent study. Diabetic CKD patients over 55 yrs old with the minor AQP11 allele had a significantly faster progression of estimated glomerular filtration rate decline than patients with the wild-type genotype. Three-dimensional structural analysis suggested a functional impairment of AQP11 with rs2276415, which could place diabetic patients at a higher risk for kidney disease. These studies identified rs2276415 as a candidate genetic factor predisposing patients with type 2 diabetes to CKD.

Citing Articles

Genetic Variants Related to Increased CKD Progression-A Systematic Review.

Mira F, Oliveiros B, Carreira I, Alves R, Ribeiro I Biology (Basel). 2025; 14(1).

PMID: 39857298 PMC: 11761907. DOI: 10.3390/biology14010068.

Peroxiporins and Oxidative Stress: Promising Targets to Tackle Inflammation and Cancer.

da Silva I, Mlinaric M, Lourenco A, Perez-Garcia O, cipak Gasparovic A, Soveral G Int J Mol Sci. 2024; 25(15).

PMID: 39125952 PMC: 11313477. DOI: 10.3390/ijms25158381.

Effects of Zinc Combined with Metformin on Zinc Homeostasis, Blood-Epididymal Barrier, and Epididymal Absorption in Male Diabetic Mice.

Zhang M, Li H, Ma J, Yang C, Yang Y, Zhao B Biol Trace Elem Res. 2024; 203(1):291-304.

PMID: 38589680 DOI: 10.1007/s12011-024-04171-y.

Relevant Membrane Transport Proteins as Possible Gatekeepers for Effective Pharmacological Ascorbate Treatment in Cancer.

Leischner C, Marongiu L, Piotrowsky A, Niessner H, Venturelli S, Burkard M Antioxidants (Basel). 2023; 12(4).

PMID: 37107291 PMC: 10135768. DOI: 10.3390/antiox12040916.

The therapeutic prospect of zinc oxide nanoparticles in experimentally induced diabetic nephropathy.

Abd El-Baset S, Mazen N, Abdul-Maksoud R, Kattaia A Tissue Barriers. 2022; 11(1):2069966.

PMID: 35504734 PMC: 9870014. DOI: 10.1080/21688370.2022.2069966.

References

Vaidya V, Niewczas M, Ficociello L, Johnson A, Collings F, Warram J . Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase. Kidney Int. 2010; 79(4):464-70. PMC: 3033751. DOI: 10.1038/ki.2010.404. View

Vallon V, Blantz R, Thomson S . The salt paradox and its possible implications in managing hypertensive diabetic patients. Curr Hypertens Rep. 2005; 7(2):141-7. DOI: 10.1007/s11906-005-0089-x. View

Huang H, Preisig P . G1 kinases and transforming growth factor-beta signaling are associated with a growth pattern switch in diabetes-induced renal growth. Kidney Int. 2000; 58(1):162-72. DOI: 10.1046/j.1523-1755.2000.00151.x. View

Hub J, de Groot B . Mechanism of selectivity in aquaporins and aquaglyceroporins. Proc Natl Acad Sci U S A. 2008; 105(4):1198-203. PMC: 2234115. DOI: 10.1073/pnas.0707662104. View

Fu W, OConnor T, Jun G, Kang H, Abecasis G, Leal S . Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature. 2012; 493(7431):216-20. PMC: 3676746. DOI: 10.1038/nature11690. View

Krolewski A, Canessa M, Warram J, Laffel L, Christlieb A, Knowler W . Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med. 1988; 318(3):140-5. DOI: 10.1056/NEJM198801213180303. View

Morishita Y, Matsuzaki T, Hara-Chikuma M, Andoo A, Shimono M, Matsuki A . Disruption of aquaporin-11 produces polycystic kidneys following vacuolization of the proximal tubule. Mol Cell Biol. 2005; 25(17):7770-9. PMC: 1190286. DOI: 10.1128/MCB.25.17.7770-7779.2005. View

Magri C, Fava S . The role of tubular injury in diabetic nephropathy. Eur J Intern Med. 2009; 20(6):551-5. DOI: 10.1016/j.ejim.2008.12.012. View

Yakata K, Tani K, Fujiyoshi Y . Water permeability and characterization of aquaporin-11. J Struct Biol. 2011; 174(2):315-20. DOI: 10.1016/j.jsb.2011.01.003. View

10.

Giunti S, Barit D, Cooper M . Mechanisms of diabetic nephropathy: role of hypertension. Hypertension. 2006; 48(4):519-26. DOI: 10.1161/01.HYP.0000240331.32352.0c. View

11.

Tesch G, Allen T . Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology (Carlton). 2007; 12(3):261-6. DOI: 10.1111/j.1440-1797.2007.00796.x. View

12.

Pezzolesi M, Skupien J, Mychaleckyj J, Warram J, Krolewski A . Insights to the genetics of diabetic nephropathy through a genome-wide association study of the GoKinD collection. Semin Nephrol. 2010; 30(2):126-40. PMC: 2847588. DOI: 10.1016/j.semnephrol.2010.01.004. View

13.

Park J, Yang S, Lee J, Yoo S, Kim Y . Genetic predisposition of donors affects the allograft outcome in kidney transplantation: Single-nucleotide polymorphism of aquaporin-11. Kidney Res Clin Pract. 2015; 34(1):47-52. PMC: 4570646. DOI: 10.1016/j.krcp.2015.01.002. View

14.

Sharfuddin A, Molitoris B . Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol. 2011; 7(4):189-200. DOI: 10.1038/nrneph.2011.16. View

15.

Rahmoune H, Thompson P, Ward J, Smith C, Hong G, Brown J . Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Diabetes. 2005; 54(12):3427-34. DOI: 10.2337/diabetes.54.12.3427. View

16.

Mason R, Wahab N . Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol. 2003; 14(5):1358-73. DOI: 10.1097/01.asn.0000065640.77499.d7. View

17.

Zerbini G, Bonfanti R, Meschi F, Bognetti E, Paesano P, Gianolli L . Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes. Diabetes. 2006; 55(9):2620-5. DOI: 10.2337/db06-0592. View

18.

Ziyadeh F, Wolf G . Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev. 2008; 4(1):39-45. DOI: 10.2174/157339908783502370. View

19.

Bonventre J, Yang L . Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest. 2011; 121(11):4210-21. PMC: 3204829. DOI: 10.1172/JCI45161. View

20.

Peltonen L, Altshuler D, de Bakker P, Deloukas P, Gabriel S, Gwilliam R . Integrating common and rare genetic variation in diverse human populations. Nature. 2010; 467(7311):52-8. PMC: 3173859. DOI: 10.1038/nature09298. View